Skip to main content

Peer Review reports

From: A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma

Original Submission
21 Jan 2018 Submitted Original manuscript
20 Feb 2018 Reviewed Reviewer Report - Roberta Meroni
25 Feb 2018 Reviewed Reviewer Report - Bernardino Alcazar
11 Apr 2018 Author responded Author comments - Veronica Swystun
Resubmission - Version 2
11 Apr 2018 Submitted Manuscript version 2
9 May 2018 Reviewed Reviewer Report - Bernardino Alcazar
31 May 2018 Author responded Author comments - Veronica Swystun
Resubmission - Version 3
31 May 2018 Submitted Manuscript version 3
Publishing
1 Jun 2018 Editorially accepted
18 Jun 2018 Article published 10.1186/s13063-018-2720-6

You can find further information about peer review here.

Back to article page